Company Information

ADVANCED ENZYME TECHNOLOGIES LTD.

NSE : ADVENZYMESBSE : 540025ISIN CODE : INE837H01020Industry : Pharmaceuticals & DrugsHouse : Private
BSE347.50-6.95 (-1.96 %)
PREV CLOSE ( ) 354.45
OPEN PRICE ( ) 355.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 10150
TODAY'S LOW / HIGH ( )345.15 357.25
52 WK LOW / HIGH ( )226.8 425.1
NSE348.45-6.1 (-1.72 %)
PREV CLOSE( ) 354.55
OPEN PRICE ( ) 353.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 348.45 (406)
VOLUME 138649
TODAY'S LOW / HIGH( ) 345.00 357.70
52 WK LOW / HIGH ( )226.1 425.15
ChairmanVasant Rathi
Company SecretarySanjay Basantani
Non Executive DirectorSunny Sharma
Promoter & Non-Executive DirectorRasika Rathi
Non Executive Independent DirectorKedar Desai
Pramod Kasat
Vinodkumar Hiralal Jajoo
Rajshree Patel
Nitin Jagannath Deshmukh
Vandana Tilak
Whole Time DirectorMukund M Kabra
Incorporation Year : 15-03 1989

Registered Office :

Address : Sun- Magnetica, A Wing,5th Floor, Near L I C Service Road,Louiswadi Thane,
Maharashtra-400604 .

Phone : 022 41703200

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.